Preferential induction of apoptotic cell death in melanoma cells as compared with normal keratinocytes using a

Shoshanna N Zucker1, Jennifer Zirnheld, Archis Bagati

  • 1Department of Biological Sciences, University at Buffalo, Buffalo, NY, USA. shoshanna.zucker@roswellpark.org

Cancer Biology & Therapy
|August 17, 2012
PubMed

Insights

Non-thermal helium plasma selectively induces apoptosis in melanoma cells, sparing normal keratinocytes. This innovative approach shows promise for melanoma treatment, even in 3D cultures.

Area of Science:

  • Biomedical Engineering
  • Dermatology
  • Plasma Physics

Background:

  • Selective apoptosis induction in melanoma is crucial for effective cancer therapy.
  • Non-thermal plasma offers a novel approach for targeted cell death induction.

Purpose of the Study:

  • To evaluate the efficacy of a modified non-thermal helium plasma torch for selective melanoma cell apoptosis.
  • To assess the plasma torch's effectiveness in various cellular environments, including 2D and 3D cultures.

Main Methods:

  • Cultured melanoma cells and human keratinocytes were exposed to helium plasma in parallel and co-culture settings.
  • Cell death was quantified after short-term exposure and longer apoptotic assessments (18-24 h).
  • Melanoma cells in a soft agar matrix (3D) were also treated to evaluate efficacy in a more complex environment.

Main Results:

  • Melanoma cells exhibited significantly higher sensitivity to plasma-induced reactive oxygen species, resulting in a 6-fold increase in cell death compared to keratinocytes.
  • A 30-second plasma exposure led to 98% melanoma cell death, demonstrating a 6-fold greater effect than on keratinocytes.
  • The plasma torch effectively induced melanoma cell death in 3D soft agar cultures, indicating potential for treating solid tumors.

Conclusions:

  • Non-thermal helium plasma can selectively induce apoptosis in melanoma cells while sparing normal keratinocytes.
  • The plasma torch demonstrates efficacy in both 2D and 3D cell culture models, suggesting its potential as a non-invasive melanoma treatment.
  • Further development of this plasma technology is warranted for clinical application in melanoma therapy.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...